GENE ONLINE|News &
Opinion
Blog

Phase 3 Trial
Trials & Approvals Anti-PD-1
Beigene’s Tislelizumab-Chemo Combo Nails Primary Endpoint in Phase 3 Trial
2020-04-16
Trials & Approvals EGFR
Overwhelming Efficacy Allows AstraZeneca to End Cancer Drug Trial Sooner
2020-04-12
COVID-19 Japan
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
Trials & Approvals Atopic Dermatitis
Regeneron & Sanofi’s Phase 3 Dupixent Data on Children Under Regulatory Review
2020-04-10
Trials & Approvals IL-31
Pfizer’s Dupixent Rival Meets Endpoints in Atopic Dermatitis Trial
2020-04-05
Trials & Approvals
GSK Reports Positive Results for Nucala in Patients with Nasal Polyps
2020-04-05
COVID-19 Remdesivir
COVID-19 Victims on Remdesivir Treatment Hopeful after First US Patient Recovers
2020-03-12
Trials & Approvals Anti-HIV
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
Asia-Pacific Atopic Dermatitis
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
R&D Classical Hodgkin Lymphoma
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
COVID-19 Remdesivir
Fight against COVID-19 Strengthens as Gilead Launches Phase III Trial for Remdesivir
2020-02-28
Trials & Approvals HER2 Inhibitor
NERLYNX-XELODA Combo Bags FDA Approval for HER2 Positive Breast Cancer Treatment
2020-02-27
Trials & Approvals Bacterial Infections
EXBLIFEP Surpasses Phase III, Presents Novel Solution for Antibiotic Resistance Crisis in Treating Complicated UTI
2020-02-26
Trials & Approvals
Relief for Patients as Baudax Bio’s Non-Opioid Analgesic Wins FDA Approval
2020-02-23
Trials & Approvals Breast Cancer
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
1 … 3 4 5 6
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top